techgroup header image oncolytic herpes simplex virus (oHSV)-rQT3 against cancer cells

oncolytic herpes simplex virus (oHSV)-rQT3 against cancer cells

Provided by: Open Therapeutics™ ; Research Institute Nationwide Children's Hospital
Tags: anti-cancer cancer Breast Cancer GPCR Cell Line
techgroup
Short Description:

Engineered oHSV lytically destroy cancer cells and stimulates the immune system to act against cancer cells.